Michael Shawn Moran
CIK 1886788 · EVP, Chief Commercial Officer · last filed 2022-03-02
Michael Shawn Moran is an EVP, Chief Commercial Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for EGRX, was dated Mar 2, 2022.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | EVP, Chief Commercial Officer | 32,115 | $2.14 | $68.7K | $0 | 5 | 2022-03-02 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-02 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | +10,400 | $0 | EDGAR |
| 2022-02-04 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −742 | -$33.4K | EDGAR |
| 2022-02-01 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −210 | -$9.6K | EDGAR |
| 2022-01-11 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −90 | -$4.6K | EDGAR |
| 2022-01-07 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −1,511 | -$76.6K | EDGAR |